Hyundai Pharmaceutical Company Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Hyundai Pharmaceutical Company Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Hyundai Pharmaceutical Company Limited. The Company's principal activity is manufacturing of pharmaceuticals and healthcare foods and drinks. Its main medical products include Tenormin tablets, for hypertension and angina pectoris; Zestril tablets, for hypertension and congest heart failure; Elroton tablets, for coronary artery diseases; Surfolase capsules, for acute or chronic respiratory diseases resulting from respiratory obstruction and disturbance in mucous secretion; Norlevo tablets, for oral emergency contraceptives, and Divina tablets, for vasomotor symptoms associated with the menopause menorrhea. The Company also produces healthcare foods for joints and cartilage, and different kinds of healthcare drinks that are made from soybeans, red ginsengs, green teas, pumpkins and others.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report